Matt TurnerPatient Affordability
Stacey GandlerBrand Nourishment
Pat PurcellMeeting Engagement
Brenda SnowAuthentic Patient Voice
Amy GilesIncreasing Engagement
Joey CohenMedication Adherence
David LinetskyPoint-of-Care Marketing
Frank BurrellScientific Storytelling
Matthew DurhamOmnidynamic Marketing
Suma Ramadas, PhDMedical Affairs
Liz KaneImpactful Strategy
Paul TheisenPatient Acquisition
Daniel SontupeMarket Access
Bud BilanichSuccess Coach
ALAMEDA, Calif., Oct. 24, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer ...
Xolair® (omalizumab), indicated as add-on therapy for the treatment of chronic spontaneous urticaria (CSU)[1], ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email